Notice NOT-MD-24-003 from the NIH Guide for Grants and Contracts

Notice NOT-AG-23-077 from the NIH Guide for Grants and Contracts

Notice NOT-NS-24-046 from the NIH Guide for Grants and Contracts

Notice NOT-AI-24-014 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-049 from the NIH Guide for Grants and Contracts

Notice NOT-GM-24-023 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-051 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AA-24-001 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) supports Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) in the development of a new, or optimization of an existing, in vivo and/or in vitro high-throughput screening (HTS) platform for use in identifying potential compounds for treating alcohol use disorder (AUD). Potential screening platform assays will consist of small vertebrate (excluding rodent) and invertebrate model organisms and human cell- and tissue-based models. The platform assays must be sensitive to different concentrations of alcohol, as well as treatment effects, such that any changes to the model can be measured accurately and reproducibly and can be used as outcome variables.

Funding Opportunity RFA-AA-24-002 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) supports Small Business Technology Transfer (STTR) applications from small business concerns (SBCs) in the development of a new, or optimization of an existing, in vivo and/or in vitro high-throughput screening (HTS) platform for use in identifying potential compounds for treating alcohol use disorder (AUD). Potential screening platform assays will consist of small vertebrate (excluding rodent) and invertebrate model organisms and human cell- and tissue-based models. The platform assays must be sensitive to different concentrations of alcohol, as well as treatment effects, such that any changes to the model can be measured accurately and reproducibly and can be used as outcome variables.

Funding Opportunity PAR-24-074 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this NOFO will support educational activities with a primary focus on: Courses for Skills Development Research Experiences These courses for skill development and research experiences must fall within NIDDK's mission areas. NIDDK supports research training skill development and research experiences on diabetes and other endocrine and metabolic diseases; digestive diseases, nutritional disorders, and obesity; and kidney, urologic, and hematologic diseases. Please refer to the NIDDK website for more information.

Notice NOT-AT-24-026 from the NIH Guide for Grants and Contracts

Notice NOT-NS-23-111 from the NIH Guide for Grants and Contracts

Notice NOT-GM-24-022 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-042 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-047 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-043 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-24-084 from the NIH Guide for Grants and Contracts. The goal of this notice of funding opportunity (NOFO) is to support feasibility trials of complementary and integrative health approaches with physical and/or psychological therapeutic inputs (often called mind and body interventions) for conditions that have been identified by NCCIH as high-priority research topics. This funding opportunity is intended to support feasibility clinical trials that provide new information that are scientifically necessary for the planning and conduct of a subsequent clinical efficacy or effectiveness study, pragmatic trial, or dissemination and implementation trial within NCCIHs mission. NCCIH expects that applications to this NOFO will describe the planned future clinical trial and in so doing demonstrate that the proposed (R34) research is scientifically necessary to design or plan the subsequent competitive full-scale clinical trial. Under this R34, the data collected should be used to fill gaps in scientific knowledge necessary to develop a competitive full-scale clinical trial, including, but not limited to the following: examining feasibility and acceptability of interventions lacking published data; tailoring or adapting the content or structure of an intervention to a specific population, modality, or setting; refining the intervention to determine the most appropriate frequency or duration; determining feasibility of recruitment, retention, and data collection procedures; refining and assessing the feasibility of protocolized multi-component interventions; or examining acceptability and adherence of control conditions. The subsequent full-scale clinical trial should have the potential to make a significant impact on public health. Prior to submitting to this NOFO, applicants are encouraged to contact the appropriate NCCIH Scientific/Research contact person for the science area of the planned application. This NOFO requires a Plan for Enhancing Diverse Perspectives (PEDP).

Notice NOT-DC-24-014 from the NIH Guide for Grants and Contracts

Notice NOT-DA-23-048 from the NIH Guide for Grants and Contracts

Notice NOT-AA-24-003 from the NIH Guide for Grants and Contracts